Home / Companies / Results / Sun Pharma Q1 net loss at Rs 1,655.6 cr, revenue down to Rs 7,585.3 cr

Sun Pharma Q1 net loss at Rs 1,655.6 cr, revenue down to Rs 7,585.3 cr

The company had posted a net profit of Rs 1,387.48 crore for the corresponding period of the previous fiscal, Sun Pharma said in a BSE filing

Sun Pharma Founder and Managing Director Dilip Shanghvi said the company would grow its speciality drug pipeline globally and expand manufacturing facilities

Premium

Shares of Sun Pharmaceutical Industries closed at Rs 531.75 per scrip on the BSE, up 4.27 per cent over the previous close.

Press Trust of India New Delhi

1 min read Last Updated : Jul 31 2020 | 4:50 PM IST

Drug major Sun Pharmaceutical Industries on Friday reported a consolidated net loss of Rs 1,655.60 crore for the quarter ended June 30, 2020.

The company had posted a net profit of Rs 1,387.48 crore for the corresponding period of the previous fiscal, Sun Pharma said in a BSE filing.

Consolidated revenue from operations stood at Rs 7,585.25 crore for the quarter under consideration as against Rs 8,374.36 crore for the same period year ago, it added.

Shares of Sun Pharmaceutical Industries closed at Rs 531.75 per scrip on the BSE, up 4.27 per cent over the previous close.

Topics : Sun Pharma Q1 results Pharma Companies

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in